MAPK9 and breast carcinoma: The analysis of JNK1-deficiency and JNK2-deficiency in the Trp53 BALB/c mouse model of mammary carcinoma development demonstrates that neither JNK1 nor JNK2 is required for breast tumorigenesis (Figures 5).